Trial Profile
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2011
Price :
$35
*
At a glance
- Drugs Botulinum toxin B (Primary) ; Botulinum-Toxin-A (Primary)
- Indications Sialorrhoea
- Focus Therapeutic Use
- 28 Mar 2011 New trial record